Craft
Genomind

Genomind

Total Funding

$32.5 M

Genomind Summary

Company summary

Overview
Genomind is a company developing a personalized medicine platform for clinicians, healthcare partners, and individuals. Its test, the Genecept Assay, is used to guide treatment for a range of psychiatric conditions, including depression, anxiety, obsessive-compulsive disorder (OCD), attention-deficit hyperactivity disorder (ADHD), bipolar and post-traumatic stress disorder (PTSD), autism, schizophrenia, etc.
Type
Private
Status
Active
Founded
2009
HQ
King of Prussia, PA, US | view all locations
Website
https://www.genomind.com/
Cybersecurity rating
Sectors

Key people

  • David Krause

    David Krause, Chief Medical Officer

    • David Robbins

      David Robbins, Chief Scientific Officer

      • Jon Levine

        Jon Levine, Chief Information Officer

        LocationsView all

        1 location detected

        • King of Prussia, PA HQ

          United States

          2200 Renaissance Blvd #100

        Footer menu